The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non-responders.

Stitt, J M; Dzieciatkowska, M; Edwards, M G; Hansen, K; Hedlund, G; Dreskin, S C

Stitt, J M; Dzieciatkowska, M; Edwards, M G; Hansen, K; Hedlund, G; Dreskin, S C.

Afiliação

Stitt JM; Division of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver School of Medicine, Aurora, CO, USA.
Dzieciatkowska M; Department of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, CO, USA.
Edwards MG; Bioinfo Solutions LLC, Parker, CO, USA.
Hansen K; Department of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, CO, USA.
Hedlund G; Division of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver School of Medicine, Aurora, CO, USA.
Dreskin SC; Division of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver School of Medicine, Aurora, CO, USA.

Clin Exp Allergy ; 48(7): 898-901, 2018 07.

Article em En | MEDLINE | ID: mdl-29671921

Assuntos

Antialérgicos/farmacologia; Basófilos/imunologia; Basófilos/metabolismo; Omalizumab/farmacologia; Proteoma; Urticária/etiologia; Urticária/metabolismo; Antialérgicos/uso terapêutico; Biomarcadores; Estudos de Casos e Controles; Doença Crônica; Humanos; Omalizumab/uso terapêutico; Proteômica/métodos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Basófilos / Antialérgicos / Proteoma / Omalizumab Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Clin Exp Allergy Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google